atorvaliq

Generic: atorvaliq

Labeler: cmp pharma, inc.
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name atorvaliq
Generic Name atorvaliq
Labeler cmp pharma, inc.
Dosage Form SUSPENSION
Routes
ORAL
Active Ingredients

atorvastatin calcium trihydrate 20 mg/5mL

Manufacturer
CMP Pharma, Inc.

Identifiers & Regulatory

Product NDC 46287-030
Product ID 46287-030_fb92775a-6d6d-4d62-ab23-045f16ec5895
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA213260
Listing Expiration 2026-12-31
Marketing Start 2023-03-01

Pharmacologic Class

Classes
hmg-coa reductase inhibitor [epc] hydroxymethylglutaryl-coa reductase inhibitors [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 46287030
Hyphenated Format 46287-030

Supplemental Identifiers

RxCUI
2630760
UNII
48A5M73Z4Q

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name atorvaliq (source: ndc)
Generic Name atorvaliq (source: ndc)
Application Number NDA213260 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 20 mg/5mL
source: ndc
Packaging
  • 150 mL in 1 BOTTLE (46287-030-01)
source: ndc

Packages (1)

46287-030-01 150 mL in 1 BOTTLE (46287-030-01)

Ingredients (1)

atorvastatin calcium trihydrate (20 mg/5mL)

Linked Drug Pages (1)

ATORVALIQ ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "fb92775a-6d6d-4d62-ab23-045f16ec5895", "openfda": {"unii": ["48A5M73Z4Q"], "rxcui": ["2630760"], "spl_set_id": ["41fca2d8-7f3f-45b9-8974-81b89accc211"], "manufacturer_name": ["CMP Pharma, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "150 mL in 1 BOTTLE (46287-030-01)", "package_ndc": "46287-030-01", "marketing_start_date": "20230301"}], "brand_name": "ATORVALIQ", "product_id": "46287-030_fb92775a-6d6d-4d62-ab23-045f16ec5895", "dosage_form": "SUSPENSION", "pharm_class": ["HMG-CoA Reductase Inhibitor [EPC]", "Hydroxymethylglutaryl-CoA Reductase Inhibitors [MoA]"], "product_ndc": "46287-030", "generic_name": "ATORVALIQ", "labeler_name": "CMP Pharma, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "ATORVALIQ", "active_ingredients": [{"name": "ATORVASTATIN CALCIUM TRIHYDRATE", "strength": "20 mg/5mL"}], "application_number": "NDA213260", "marketing_category": "NDA", "marketing_start_date": "20230301", "listing_expiration_date": "20261231"}